The see-saw of Keap1-Nrf2 pathway in cancer

Adams, 2000, The kelch repeat superfamily of proteins: propellers of cell function, Trends Cell Biol., 10, 17, 10.1016/S0962-8924(99)01673-6 Aoki, 2001, Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust, Toxicol. Appl. Pharmacol., 173, 154, 10.1006/taap.2001.9176 Balendiran, 2004, The role of glutathione in cancer, Cell Biochem. Funct., 22, 343, 10.1002/cbf.1149 Becks, 2010, Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7, 12-dimethylbenz [a] anthracene, BMC Cancer, 10, 1, 10.1186/1471-2407-10-540 Brandt, 2014, Indole-3-carbinol attenuates the deleterious gestational effects of bisphenol A exposure on the prostate gland of male F1 rats, Reprod. Toxicol., 43, 56, 10.1016/j.reprotox.2013.11.001 Breimer, 1990, Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage, Mol. Carcinog., 3, 188, 10.1002/mc.2940030405 Chian, 2014, Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo, Biochem. Biophys. Res. Commun., 447, 602, 10.1016/j.bbrc.2014.04.039 Chien, 2015, Keap1–Nrf2 interaction suppresses cell motility in lung adenocarcinoma by targeting the S100P protein, Clin. Cancer Res., 21, 4719, 10.1158/1078-0432.CCR-14-2880 Cho, 2008, Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance, Cancer Lett., 260, 96, 10.1016/j.canlet.2007.10.022 Cullinan, 2004, The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase, Mol. Cell Biol., 24, 8477, 10.1128/MCB.24.19.8477-8486.2004 Dinkova-Kostova, 2002, Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants, Proc. Natl. Acad. Sci. U. S. A., 99, 11908, 10.1073/pnas.172398899 Dinkova-Kostova, 2005, The role of Keap1 in cellular protective responses, Chem. Res. Toxicol., 18, 1779, 10.1021/tx050217c Douglas, 1987, Mechanism of action of glutathione-dependent enzymes, Adv. Enzymol. Relat. Areas Mol. Biol., 59, 103 Eggler, 2009, Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1, Biochem. J., 422, 171, 10.1042/BJ20090471 Furukawa, 2005, BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase, Mol. Cell Biol., 25, 162, 10.1128/MCB.25.1.162-171.2005 Ganan-Gomez, 2013, Oncogenic functions of the transcription factor Nrf2, Free Radic. Biol. Med., 65, 750, 10.1016/j.freeradbiomed.2013.06.041 Gao, 2004, Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage, Proc. Natl. Acad. Sci. U. S. A, 101, 10446, 10.1073/pnas.0403886101 Hanada, 2012, Methylation of the KEAP1 gene promoter region in human colorectal cancer, BMC Cancer, 12, 1, 10.1186/1471-2407-12-66 Hartikainen, 2015, KEAP1 genetic polymorphisms associate with breast cancer risk and survival outcomes, Clin. Cancer Res., 21, 1591, 10.1158/1078-0432.CCR-14-1887 Hayes, 2014, The Nrf2 regulatory network provides an interface between redox and intermediary metabolism, Trends Biochem. Sci., 39, 199, 10.1016/j.tibs.2014.02.002 Hayes, 2009, NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer, Trends Biochem. Sci., 34, 176, 10.1016/j.tibs.2008.12.008 Hayes, 2005, Glutathione transferases, Annu. Rev. Pharmacol. Toxicol., 45, 51, 10.1146/annurev.pharmtox.45.120403.095857 Hirotsu, 2012, Nrf2–MafG heterodimers contribute globally to antioxidant and metabolic networks, Nucleic Acids Res., 40, 10228, 10.1093/nar/gks827 Hsieh, 2009, Regulation of shear-induced nuclear translocation of the Nrf2 transcription factor in endothelial cells, J. Biomed. Sci., 16, 1, 10.1186/1423-0127-16-12 Iida, 2004, Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis, Cancer Res., 64, 6424, 10.1158/0008-5472.CAN-04-1906 Ikeda, 2004, Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepato-carcinogenesis, Biochem. J, 380, 515, 10.1042/bj20031948 Iqbal, 2003, Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity, Pharmacol. Toxicol., 92, 33, 10.1034/j.1600-0773.2003.920106.x Itoh, 1997, An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements, Biochem. Biophys. Res. Commun., 236, 313, 10.1006/bbrc.1997.6943 Jaiswal, 2004, Nrf2 signaling in coordinated activation of antioxidant gene expression, Free Radic. Biol. Med., 36, 1199, 10.1016/j.freeradbiomed.2004.02.074 aramillo, 2013, The emerging role of the Nrf2–Keap1 signaling pathway in cancer, Genes Dev., 27, 2179, 10.1101/gad.225680.113 Jozkowicz, 2007, Heme oxygenase-1 in tumors: is it a false friend?, Antioxid. Redox. Signal., 9, 2099, 10.1089/ars.2007.1659 Kannan, 2012, The small MAF transcription factors MAFF, MAFG and MAFK: current knowledge and perspectives, BBA-Mol. Cell Res., 1823, 1841 Kaspar, 2009, Nrf2: INrf2 (Keap1) signaling in oxidative stress, Free Radic. Biol. Med., 47, 1304, 10.1016/j.freeradbiomed.2009.07.035 Katoh, 2001, Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription, Genes Cells, 6, 857, 10.1046/j.1365-2443.2001.00469.x Khatri, 2015, Aromatase inhibitor—mediated downregulation of INrf2 (Keap1) leads to increased nrf2 and resistance in breast cancer, Mol. Cancer Ther., 14, 1728, 10.1158/1535-7163.MCT-14-0672 Khor, 2008, Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer, Cancer Prev. Res., 1, 187, 10.1158/1940-6207.CAPR-08-0028 Kim, 2007, Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer, Clin. Cancer Res., 13, 3875, 10.1158/1078-0432.CCR-06-2893 Kim, 2007, Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology, Cancer Res., 67, 546, 10.1158/0008-5472.CAN-06-2401 Kim, 2008, Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities, Nat. Rev. Drug Discov., 7, 1013, 10.1038/nrd2755 Kobayashi, 2006, Nrf2–Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species, Adv. Enzyme Regul., 46, 113, 10.1016/j.advenzreg.2006.01.007 Kobayashi, 2009, The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds, Mol. Cell Biol., 29, 493, 10.1128/MCB.01080-08 Konstantinopoulos, 2011, Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer, Cancer Res., 71, 5081, 10.1158/0008-5472.CAN-10-4668 Kwak, 2001, Role of phase 2 enzyme induction in chemoprotection by dithiolethiones, Mutat. Res./Fund. Mol. Mech. Mut., 480, 305, 10.1016/S0027-5107(01)00190-7 Kwak, 2001, Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione, Mol. Med., 7, 135, 10.1007/BF03401947 Lau, 2008, Dual roles of Nrf2 in cancer, Pharmacol. Res., 58, 262, 10.1016/j.phrs.2008.09.003 Lee, 2009, KEAP1 E3 ligase-mediated downregulation of NF-κB signaling by targeting IKKβ, Mol. Cell, 36, 131, 10.1016/j.molcel.2009.07.025 Lee, 2009, Induction of the phase II detoxification enzyme NQO1 in hepatocarcinoma cells by lignans from the fruit of Schisandra chinensis through nuclear accumulation of Nrf2, Planta Med., 75, 1314, 10.1055/s-0029-1185685 Lee, 2015, Heme oxygenase-1 determines the differential response of breast cancer and normal cells to piperlongumine, Mol. Cells, 38, 327, 10.14348/molcells.2015.2235 Levonen, 2004, Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products, Biochem. J., 378, 373, 10.1042/bj20031049 Li, 1992, Regulation of human NAD (P) H: quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element, J. Biol. Chem., 267, 15097, 10.1016/S0021-9258(18)42151-5 Li, 2011, KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma, J. Hum. Genet., 56, 230, 10.1038/jhg.2010.172 Lo, 2006, PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex, J. Biol. Chem., 281, 37893, 10.1074/jbc.M606539200 Mahaffey, 2009, Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma, Free Radic. Biol. Med., 46, 1650, 10.1016/j.freeradbiomed.2009.03.023 Marzec, 2007, Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury, FASEB J., 21, 2237, 10.1096/fj.06-7759com McMahon, 2010, Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals, Proc. Natl. Acad. Sci. U. S. A., 107, 18838, 10.1073/pnas.1007387107 McWalter, 2004, Transcription factor Nrf2 is essential for induction of NAD (P) H: quinone oxidoreductase 1, glutathione S-transferases, and glutamate cysteine ligase by broccoli seeds and isothiocyanates, J. Nutr., 134, 3499S, 10.1093/jn/134.12.3499S Meijerman, 2008, Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer, Cancer Treat Rev., 34, 505, 10.1016/j.ctrv.2008.03.002 Menegon, 2016, The dual roles of NRF2 in cancer, Trends Mol. Med., 10.1016/j.molmed.2016.05.002 Morimitsu, 2002, A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway, J. Biol. Chem., 277, 3456, 10.1074/jbc.M110244200 Motohashi, 2004, Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1–Nrf2 regulatory pathway, Proc. Natl. Acad. Sci. U. S. A., 101, 6379, 10.1073/pnas.0305902101 Nioi, 2007, A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity, Biochem. Biophys. Res. Commun., 362, 816, 10.1016/j.bbrc.2007.08.051 Nioi, 2005, The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation, Mol. Cell Biol., 25, 10895, 10.1128/MCB.25.24.10895-10906.2005 Niture, 2014, Regulation of nrf2—an update, Free Radic. Biol. Med., 66, 36, 10.1016/j.freeradbiomed.2013.02.008 Ohta, 2008, Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth, Cancer Res., 68, 1303, 10.1158/0008-5472.CAN-07-5003 Okawa, 2006, Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity, Biochem. Biophys. Res. Commun., 339, 79, 10.1016/j.bbrc.2005.10.185 Olayanju, 2015, Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity—implications for therapeutic targeting of Nrf2, Free Radic. Biol. Med., 78, 202, 10.1016/j.freeradbiomed.2014.11.003 Padmanabhan, 2006, Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer, Mol. Cell, 21, 689, 10.1016/j.molcel.2006.01.013 Philips, 1998, Identification of Kel1p, a kelch domain-containing protein involved in cell fusion and morphology in Saccharomyces cerevisiae, ‎J. Cell Biol., 143, 375, 10.1083/jcb.143.2.375 Pi, 2008, Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2, Free Radic. Biol. Med., 45, 651, 10.1016/j.freeradbiomed.2008.05.020 Pool-Zobel, 2005, Modulation of xenobiotic metabolising enzymes by anticarcinogens—focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis, Mutat. Res./Fund. Mol. Mech. Mut., 591, 74, 10.1016/j.mrfmmm.2005.04.020 Ramos-Gomez, 2003, Interactive effects of nrf2 genotype and oltipraz on benzo [a] pyrene—DNA adducts and tumor yield in mice, Carcinogenesis, 24, 461, 10.1093/carcin/24.3.461 Rangasamy, 2004, Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice, J. Clin. Invest., 114, 1248, 10.1172/JCI200421146 Sahin, 2014, Orally administered lycopene attenuates diethylnitrosamine-induced hepatocarcinogenesis in rats by modulating Nrf-2/HO-1 and Akt/mTOR pathways, Nutr. Cancer, 66, 590, 10.1080/01635581.2014.894092 Sarma, 1985, Liver tumour promotion by chemicals: models and mechanisms, Cancer Surv., 5, 781 Sau, 2010, Glutathione transferases and development of new principles to overcome drug resistance, Arch. Biochem. Biophys., 500, 116, 10.1016/j.abb.2010.05.012 Shen, 2015, A curcumin derivative that inhibits vinyl carbamate-induced lung carcinogenesis via activation of the Nrf2 protective response, Antioxid. Redox Signal., 23, 651, 10.1089/ars.2014.6074 Shibata, 2008, Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer, Gastroenterology, 135, 1358, 10.1053/j.gastro.2008.06.082 Shibata, 2008, Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy, Proc. Natl. Acad. Sci. U. S. A., 105, 13568, 10.1073/pnas.0806268105 Singh, 2006, Dysfunctional KEAP1–NRF2 interaction in non-small-cell lung cancer, PLoS Med., 3, e420, 10.1371/journal.pmed.0030420 Sporn, 2012, NRF2 and cancer: the good, the bad and the importance of context, Nat. Rev. Cancer, 12, 564, 10.1038/nrc3278 Suzuki, 2013, Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels, Mol. Cell Biol., 33, 2402, 10.1128/MCB.00065-13 Taguchi, 2010, Genetic analysis of cytoprotective functions supported by graded expression of Keap1, Mol. Cell Biol., 30, 3016, 10.1128/MCB.01591-09 Tian, 2012, Keap1: one stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL, Cancer Lett., 325, 26, 10.1016/j.canlet.2012.06.007 Tong, 2006, Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism, Biol. Chem., 387, 1311, 10.1515/BC.2006.164 Villeneuve, 2013, USP15 negatively regulates Nrf2 through deubiquitination of Keap1, Mol. Cell, 51, 68, 10.1016/j.molcel.2013.04.022 Volate, 2004, Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements, Cancer Res., 64, 73 World Cancer Report, 2014. World Health Organization. 2014. pp. Chapter 1.1. ISBN 9283204298. Wakabayashi, 2003, Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation, Nat. Genet., 35, 238, 10.1038/ng1248 Wakabayashi, 2010, When NRF2 talks, who's listening?, Antioxid. Redox. Signal., 13, 1649, 10.1089/ars.2010.3216 Wang, 2008, Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues, Biochem. Biophys. Res. Commun., 373, 151, 10.1016/j.bbrc.2008.06.004 Wang, 2008, Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2, Carcinogenesis, 29, 1235, 10.1093/carcin/bgn095 Wang, 2013, RXRα inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2, Cancer Res., 73, 3097, 10.1158/0008-5472.CAN-12-3386 Yoo, 2012, Somatic mutations of the KEAP1 gene in common solid cancers, Histopathology, 60, 943, 10.1111/j.1365-2559.2012.04178.x You, 2011, Transcription factor Nrf2 maintains the basal expression of Mdm2: An implication of the regulation of p53 signaling by Nrf2, Arch. Biochem. Biophys., 507, 356, 10.1016/j.abb.2010.12.034 Yuan, 2008, Protective effects of epigallocatechin gallate on colon preneoplastic lesions induced by 2-amino-3-methylimidazo [4,5-f] quinoline in mice, Mol. Med., 14, 590, 10.2119/2007-00050.Yuan Zhang, 2003, Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress, Mol. Cell Biol., 23, 8137, 10.1128/MCB.23.22.8137-8151.2003 Zhang, 2004, Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex, Mol. Cell Biol., 24, 10941, 10.1128/MCB.24.24.10941-10953.2004 Zhang, 2009, Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice, Chin. Med. J., 122, 1660 Zhang, 2010, Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth, Mol. Cancer Ther., 9, 336, 10.1158/1535-7163.MCT-09-0589 Zhang, 2015, Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma, BMC Cancer, 15, 1, 10.1186/s12885-015-1541-1 Zhang, 2006, Mechanistic studies of the Nrf2-Keap1 signaling pathway, Drug Metab. Rev., 38, 769, 10.1080/03602530600971974 Zipper, 2002, The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm, J. Biol. Chem., 277, 36544, 10.1074/jbc.M206530200 de Visser, 2009, Towards understanding the role of cancer-associated inflammation in chemoresistance, Curr. Pharm. Des., 15, 1844, 10.2174/138161209788453239